Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/SOLIGENIX-INC-32430006/actualite/Soligenix-Inc-recoit-l-autorisation-de-la-FDA-pour-un-essai-clinique-de-phase-2-sur-l-hypericine-40854363/?utm_source=whatsapp&utm_medium=social&utm_campaign=share